|
|||||
|
|
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants |
|
| Authors: | Mathieu Ferrari Leila Mekkaoui F. Tudor Ilca Zulaikha Akbar Reyisa Bughda Katarina Lamb Katarzyna Ward Farhaan Parekh Rajeev Karattil Christopher Allen Philip Wu Vania Baldan Giada Mattiuzzo Emma M. Bentley Yasuhiro Takeuchi James Sillibourne Preeta Datta Alexander Kinna Martin Pule Shimobi C. Onuoha |
| Affiliation: | a Autolus Limited, The MediaWorks, London, United Kingdom ; b National Institute for Biological Standards and Control, Herts, United Kingdom ; c Division of Infection and Immunity, University College London, London, United Kingdom |
| Abstract: | |
| Keywords: | |